GlassScriptPhysician profile
Nikhil Verma
NPI 1487041232
$23,708.16
in general payments reported to CMS, 2019-2025
25 companies · $1,911 in 2025
The $1,911 reported for 2025 was more than what 93% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $782 · 2020: $358 · 2021: $7,959 · 2022: $5,675 · 2023: $6,027 · 2024: $996 · 2025: $1,911.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,863 · Travel and Lodging: $3,938 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,862.78 |
| Travel and Lodging | $3,938.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $133.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $5,592.45 | 2022-2025 | Reactiv8 |
| Terumo Bct, INC. | $5,259.33 | 2021 | |
| Saluda Medical Americas, INC. | $2,823.79 | 2023-2025 | Evoke Scs, Evoke |
| Boston Scientific Corporation | $2,289.10 | 2021-2025 | General - Therapies, General - Pain Management, Wavewriter Alpha Prime 16 |
| Spinal Simplicity, LLC | $1,690.86 | 2021-2025 | Ha Minuteman G3-R |
| Nevro Corp. | $1,519.76 | 2020-2024 | Senza |
| Relievant Medsystems, INC. | $1,295.30 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $1,265.88 | 2025 | Iovera, Zilretta |
| Vertos Medical, INC. | $484.82 | 2021-2023 | Mild Device Kit |
| Medtronic, INC. | $466.46 | 2021-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Curonix LLC | $374.23 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nalu Medical, INC. | $208.38 | 2022-2023 | Nalu Neurostimulation System |
| Abbott Laboratories | $117.13 | 2022-2024 | Proclaim, Eterna |
| Siemens Medical Solutions USA, INC. | $68.35 | 2023 | |
| Painteq LLC | $38.80 | 2023 | Painteq |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $33.50 | 2021 | |
| Abbvie INC. | $32.84 | 2022 | |
| Si-Bone, INC. | $30.08 | 2025 | |
| Novo Nordisk INC | $25.00 | 2022 | |
| Amgen INC. | $20.40 | 2021 | |
| Allergan, INC. | $20.01 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $15.03 | 2022 | |
| Convatec INC. | $14.41 | 2023 | |
| Fidia Pharma USA INC. | $11.76 | 2022 | |
| Spr Therapeutics, INC | $10.49 | 2024 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikhil Verma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.